Article
Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma2 (PPARgamma2) is associated with higher levels of total cholesterol and LDL-cholesterol in male caucasian type 2 diabetes patients.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association - 1 Apr 2002
Zietz B, Barth N, Spiegel D, Schmitz G, Schölmerich J, Schäffler A
Abstract excerpt
UNLABELLED: The peroxisome proliferator-activated receptor-gamma2 (PPAR(gamma2)) represents the transcriptional master regulator of adipocyte differentiation and therefore has been suggested as candidate gene for the pathogenesis of obesity, type 2 diabetes and related metabolic disorders. Aim of our study was to determine the frequency of a missense point mutation within exon 2 of PPAR(gamma2), Pro12Ala, and its...
Topics
- Aged
- Alanine
- Alleles
- Cholesterol
- Cholesterol, LDL
- Cohort Studies
- Diabetes Mellitus, Type 2
- Female
- Heterozygote
- Homozygote
